Background Chest CT is a widely accessible imaging modality that facilitates timely evaluation in patients suspected of COVID-19. As SARS-CoV-2 mutated over time, identifying differences in radiologic presentation can aid clinical management. Methods In this retrospective study, we examined chest CT scans of 360 patients with confirmed COVID-19 via RT PCR, divided into 2 equal groups: 180 with mutated COVID-19 (predominantly Delta variant) and 180 with early (original) COVID-19. All participants were aged 20 to 50 years and had no underlying medical conditions. CT findings were analyzed for ground glass opacities (GGOs), consolidation, nodules, pleural/pericardial effusion, bronchial wall thickening, subpleural banding, number of lobes involved, and estimated lung conflict. Statistical analyses were conducted using SPSS v24. Results GGO was found in 77.2% of mutated COVID-19 patients and 83.3% of early COVID-19 patients ( P = 0.145). Consolidation and reverse halo sign were significantly more frequent in mutated cases (63.3% and 18.3%) than early COVID-19 (48.9%, 9.4%) ( P < 0.05). Conversely, nodules, halo sign, pleural and pericardial effusions, and subpleural banding were more prevalent in early COVID-19 ( P < 0.05). Average number of lobes involved and lung conflict percentage were higher in mutated cases (2.92 lobes, 58.8%) compared to early COVID-19 (2.63 lobes, 34.8%) ( P < 0.001). Conclusions Although GGO and bronchial thickening were common across both groups, mutated COVID-19 showed increased consolidation and lung conflict. Early COVID-19 showed higher rates of nodules, halo signs, and effusions. These findings reflect underlying variations in pathophysiologic response and viral evolution.
No takes yet. Share an insight, caveat, or question.
Dahmardeh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: